Active nausea or reflux indicates that gastric emptying is actively delayed, which severely increases aspiration risks and heavily influences whether your care team will choose to pause the medication
Food and Drug Administration (FDA) database from 2004 to 2009 reported increased risks of pancreatic and thyroid cancer associated with the GLP-1 receptor agonist (GLP-1RA) exenatide compared to other therapies [8]
Rapid dose escalation increases your risk of severe side effects and may actually interfere with your weight loss goals
12,000+ delicious recipes And restaurant guides to help you navigate groceries (and drive-thrus) with ease
For a woman over 40 whos already losing muscle due to aging and menopause, losing even more muscle through GLP-1-assisted weight loss is a disaster for long-term metabolism, strength, bone density, and how you look and feel
Do you accept HSA/FSA for medical weight loss